Form 4: Longeveron Director Rock Soffer Receives 23,500 Restricted Stock Units

Director Rock Soffer was awarded 23,500 Restricted Stock Units (RSUs) in Longeveron Inc. on August 15, 2024.

Summary

• On August 15, 2024, Rock Soffer, a director of Longeveron Inc., received 23,500 Restricted Stock Units (RSUs).
• These RSUs are time-based vesting awards.
• Following this transaction, Soffer beneficially owns a total of 232,034 shares, including RSUs subject to future vesting and 41,050 shares of Class B common stock.
• Class B Common Stock has identical rights to holders of common stock, except that holders of Class B Common Stock are entitled to 5 votes for each share held of record.
• Each share of Class B Common Stock is convertible at any time, at the option of the holder, into one share of common stock.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. The granting of RSUs is a standard practice and indicates alignment of interests between the director and shareholders. There are no explicit negative implications.

Positives

• The award of RSUs to a director aligns their interests with the long-term performance of the company.
• The director's increased stake in the company demonstrates confidence in its future prospects.

Industry Context

This type of equity compensation is common for directors and executives in publicly traded companies to incentivize performance and align interests with shareholders.

Comparison to Industry Standards

• Equity grants to directors are a standard practice across the biotechnology industry.
• The size of the grant is typical for a company of Longeveron's size and market capitalization.
• Similar companies such as Lineage Cell Therapeutics and BioTime also use RSUs as part of their director compensation packages.

Stakeholder Impact

• Shareholders may view the RSU grant positively as it aligns the director's interests with the company's long-term success.
• Employees may see this as a positive sign of the company's commitment to its leadership.

Key Dates